N-(2-(2-Benzilidenehydrazinecarbonyl)phenyl)benzamides: Synthesis, Cytotoxic, Antioxidant Activity and Molecular Docking Studies

Melanny Ika Sulistyowaty, Galih Satrio Putra, Wang Zhichao, Tutuk Budiati

Abstract

This study’s purpose was to continue our research by acquiring novel anticancer candidates, the derivatives of N-(2-(2-benzylidenehydrazinecarbonyl)phenyl)benzamide. The benzamides were synthesized from the starting material, anthranilic acid. The products were examined for their antioxidant activity and bioactivity against human lung cancer in cell line A549. This study also reported the molecular interaction with tyrosine kinase (PDB ID: 1M17) by in silico method. The synthesis was conducted in three reaction steps, consisting of nucleophilic substitution, dehydration reaction, and nucleophilic addition. In vitro anticancer activity of the compounds was examined in the A549 cell line by using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) method. Free radical scavenger activity of these compounds was also evaluated by DPPH (2,2,1-diphenyl-1-picrylhydrazyl) assay. The virtual molecular docking study was performed using Molegro® version 5.5. The derivatives of N-(2-(2-benzylidenehydrazinecarbonyl)phenyl)benzamide were synthesized in good yields. Among the synthesized compounds, N-(2-(2-(2-hydroxybenzylidene)hydrazinecarbonyl)phenyl)benzamide (3c) had the highest activity in terms of inhibiting the growth of the A549 cell line, with IC50 of 10.88 ± 0.82 μg/mL, which was linear with the docking result. Meanwhile, N-(2-(2-(4-hydroxy-3-methoxybenzylidene)hydrazinecarbonyl)phenyl)benzamide (3f) possessed the highest antioxidant activity, with IC50 of 37.23 ± 3.76 μg/mL.

 

 

Keywords: synthesis, benzamides, cancer, antioxidant, PDB ID 1M17, A549.


Full Text:

PDF


References


SULISTYOWATY M. I., PUTRA G. S., BUDIATI T., et al. MATSUNAMI, K. Synthesis, In Vitro Anticancer Activity and in Silico Study of Some Benzylidenehydrazide Derivatives. Key Engineering Materials, 2020, 840:277-83. https://doi.org/10.4028/www.scientific.net/KEM.840.277.

COCCO M.T., CONGIU C., LILLIU V., et al. Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents., Bioorganic & Medicinal Chemistry Letters, 2004, 14(23): 5787-91. https://doi.org/10.1016/j.bmcl.2004.09.045.

RAGHAVAN S., TRIA G.S., SHEN H.C., et al. Tetrahydro anthranilic acid as a surrogate for anthranilic acid: application to the discovery of potent niacin receptor agonists. Bioorganic & Medicinal Chemistry Letters, 2008, 18(11): 3163-67. https://doi.org/https://doi.org/10.1016/j.bmcl.2008.04.071.

JIAO Qinlian, BI Lei, REN Yidan, et al. Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Molecular Cancer, 2018, 17: 36-48. https://doi.org/10.1186/s12943-018-0801-5.

The National Comprehensive Cancer Network Clinical Practice Guideline in Oncology (NCCN Guideline ®), Non-Small Cell Lung Cancer. 2017, 1-211.

LV, Peng-Cheng , ZHOU, Chang-Fang , CHEN, Jin, et al. Design, synthesis and biological evaluation of Thiazolidinone derivatives as potential EGFR and HER-2 inhibitors. Bioorganic & Medicinal Chemistry, 2010, 18: 314-9. https://doi.org/10.1016/j.bmc.2009.10.051.

NOOLVI M.N., PATEL H. M., BHARDWAJ V., et al. Synthesis and in vitro antitumor activity of substituted quinazoline andquinoxaline derivatives: Search for anticancer agent. European Journal of Medicinal Chemistry, 2011, 46: 2327-46. https://doi.org/10.1016/j.ejmech.2011.03.015.

TIWARI A. K., SINGH V. K., BAJPAI A., et al. Synthesis and biological properties of 4-(3H)-quinazolone derivatives. European Journal of Medicinal Chemistry, 2007, 42: 1234-38. https://doi.org/10.1016/j.ejmech.2007.01.002.

NANDA A.K., GANGULI S., and CHAKRABORTY R. Antibacterial activity of some 3-(Arylidenamino)-2-phenylquinazoline-4(3H)-ones: Synthesis and Preliminary QSAR studies. Molecules, 2007, 12(10): 2413-26. https://doi.org/10.3390/12102413.

PUTRA G. S., WIDIYANA A. P., MUCHLASHI L. A., et al. The Influence of ratio pyridine and triethylamine catalysts on synthesis 2-phenyl-benzo[D] [1,3]oxazine-4-on derivatives. Journal of Chemical and Pharmaceutical Research, 2017, 9(8): 73-80.

WIDIYANA A. P., PUTRA G. S., SULISTYOWATY M. I., et al. Synthesis, method optimization of 2, 3-disubstitutedquinazolin-4(3H)-one derivatives. Journal of Chemical and Pharmaceutical Research, 2017, 9(8): 24-28.

MATSUNAMI K., TAKAMORI I., SHINZATO T., et al. Radical-scavenging activities of new megastimane glucosides from Macaranga tanarius (L.) MULL-ARG, Chemical Pharmaceutical Bulletin, 2006, 54: 1403–07. https://doi.org/10.1248/cpb.54.1403.

WIDYOWATI R., SUGIMOTO S., YAMANO Y., et al. New Isolinariins C, D and E, Flavonoid Glycosides from Linaria Japonica, Chemical Pharmaceutical Bulletin, 2016, 64: 517–21. https://doi.org/ 10.1248/cpb.c16-00073.

SAMY M. N., KHALIL, H. E. SUGIMOTO, S. et al. Biological studies on chemical constituents of Ruellia patula and Ruellia tuberose. Journal of Pharmacognosy and Phytochemistry, 2015, 4(1): 64-7.

WIDIANDANI T.,, SISWANDONO S., MEIYANTO E., et al. New N-allylthiourea derivatives: synthesis, molecular docking and in vitro cytotoxicity studies. Tropical Journal Pharmaceutical Research, 2018, 17(8): 1607-13. https://doi.org/ 10.4314/tjpr.v17i8.20.

YOUNG D.C. Computational drug design. A guide for computational and medicinal chemists. New York: John Wiley and Sons, 2009.

KHAN R., TAZMAN A., GURBUZ D., et al. Synthesis and Structural Characterization of N-(2-{[(2E)-2-(2-Hydroxybenzylidene)hydrazinyl]carbonyl}-phenyl)-benzamide(HL) and its Co(II), Fe(III), Cu(II) AND Zn(II) complexes X-ray Chrystal Structure of HL. Bulletin Chemical Society of Ethiopia, 2018, 32(1): 111-24. https://doi.org/10.4314/bcse.v32i1.10.

TONCIO C.B., ÁLVAREZ J.A., CAMPOS F., et al. Dictyostelium discoideum as a surrogate host–microbe model for antivirulence screening in Pseudomonas aeruginosa PAO1. International Journal of Antimicrobial Agents, 2016, 47: 403–9. https://doi.org/ 10.1016/j.ijantimicag.2016.02.005.

BURDA-GRABOWSKA M., MACEGONIUK K., FLICK R., et al. Bisphosphonic acids and related compounds as inhibitors of nucleotide and polyphosphate processing enzymes: A PPK1 and PPK2 Case Study, Chemical Biology and Drug Design, 2019, 93(6): 1197-1206. https://doi.org/ 10.1111/cbdd.13439.

BATISTA R., SILVA, A. de J., Jr., OLIVEIRA A. B. Plant derived antimalarial agents: New Leads and efficient phytomedicines. Part II. Non alkaloidal natural products, Molecules, 2009, 14: 3037-72. https://doi.org/ 10.3390/molecules14083037.

COS P., VLIETINCK A. J., BERGHE D. V., et al. Anti-infective potential of natural products: How to develop a stronger in vitro proof-of-concept. Journal of Ethnopharmacology, 2006, 106: 290–302. https://doi.org/10.1016/j.jep.2006.04.003.

WEERAPREEYAKUL N., NONPUNYA A., BARUSRUX S., et al. Evaluation of the anticancer potential of six herbs against a hepatoma cell line. Chinese Medicine, 2012, 7(1):15. https://doi.org/ 10.1186/1749-8546-7-15.

PROTEIN DATA BANK, n.d. https://www.wwpdb.org/


Refbacks

  • There are currently no refbacks.